The store will not work correctly when cookies are disabled.
4-Acetamidophenyl 2-morpholinoacetate
ID: ALA1795484
PubChem CID: 56680029
Max Phase: Preclinical
Molecular Formula: C14H18N2O4
Molecular Weight: 278.31
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Synonyms: 4-Acetamidophenyl 2-Morpholinoacetate | CHEMBL1795484|4-Acetamidophenyl 2-Morpholinoacetate
Synonyms from Alternative Forms(1): 4-Acetamidophenyl 2-Morpholinoacetate HCl
Canonical SMILES: CC(=O)Nc1ccc(OC(=O)CN2CCOCC2)cc1
Standard InChI: InChI=1S/C14H18N2O4/c1-11(17)15-12-2-4-13(5-3-12)20-14(18)10-16-6-8-19-9-7-16/h2-5H,6-10H2,1H3,(H,15,17)
Standard InChI Key: NGIBPJSZEFCBGL-UHFFFAOYSA-N
Molfile:
RDKit 2D
20 21 0 0 0 0 0 0 0 0999 V2000
0.0243 0.4125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7387 0.8250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0243 -0.4125 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-0.6902 0.8250 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.8822 -0.4125 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.1677 -0.8250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4532 -0.4125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4532 0.4125 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.1677 0.8250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8822 0.4125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.4047 0.4125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.4047 -0.4125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.1191 -0.8250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.8336 -0.4125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.8336 0.4125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.1191 0.8250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.2625 -0.4125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.9770 -0.8250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.2625 0.4125 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-3.5481 -0.8250 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
1 3 2 0
1 4 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 9 1 0
9 10 1 0
5 10 1 0
2 8 1 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 16 1 0
11 16 2 0
17 18 1 0
17 19 2 0
17 20 1 0
14 20 1 0
4 11 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 278.31 | Molecular Weight (Monoisotopic): 278.1267 | AlogP: 0.88 | #Rotatable Bonds: 4 |
Polar Surface Area: 67.87 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 4.21 | CX LogP: 0.49 | CX LogD: 0.49 |
Aromatic Rings: 1 | Heavy Atoms: 20 | QED Weighted: 0.65 | Np Likeness Score: -1.71 |
References
1. Devarajan-Ketha H, Sloan KB.. (2011) N,N'-Dialkylaminoalkylcarbonyl (DAAC) prodrugs and aminoalkylcarbonyl (AAC) prodrugs of 4-hydroxyacetanilide and naltrexone with improved skin permeation properties., 21 (13): [PMID:21616664] [10.1016/j.bmcl.2011.04.118] |